CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Cash Flow Report and Market Update 30 Sep 2020, page-7

  1. 190 Posts.
    lightbulb Created with Sketch. 12
    Assume they are looking at the joint health supplement as income stream, hopefully this quarter.
    They weren't cheap and sold very quickly on Amazon. The reviews were universally very positive, especially from buyers with older dogs.

    Agree with your comments regarding CPAT-01, which is the main game.
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.